Cargando…

Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer

BACKGROUND: We investigated the relationship between 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG-PET-CT) standardized uptake value (SUV) and 21-gene recurrence score (RS) in estrogen receptor (ER)-positive/HER2-negative breast cancer. MATERIALS AND METHODS: One h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Sung Gwe, Lee, Jae-Hoon, Lee, Hak Woo, Jeon, Tae Joo, Ryu, Young Hoon, Kim, Kun Min, Sohn, Joohyuk, Yun, Mijin, Lee, Seung Ah, Jeong, Joon, Kim, Seung Il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395149/ https://www.ncbi.nlm.nih.gov/pubmed/28419166 http://dx.doi.org/10.1371/journal.pone.0175048

Ejemplares similares

(18)F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence
por: Kim, Hyun Jeong, et al.
Publicado: (2022)

Standardized uptake value of (18)F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Prognostic significance of bone marrow and spleen (18)F-FDG uptake in patients with colorectal cancer
por: Lee, Jae-Hoon, et al.
Publicado: (2021)

Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay
por: Ahn, Sung Gwe, et al.
Publicado: (2017)

The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by (18)F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer
por: Song, Bong-Il, et al.
Publicado: (2015)

Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer
por: Yoon, Hai-Jeon, et al.
Publicado: (2018)

Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer
por: Ji, Jung Hwan, et al.
Publicado: (2022)

Metabolic tumour volume on (18)F-FDG PET/CT predicts extended pathological T stages in patients with renal cell carcinoma at staging
por: Kim, Dongwoo, et al.
Publicado: (2021)

Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
por: Bae, Soong June, et al.
Publicado: (2021)

[18F]-Fluorodeoxyglucose Positron Emission Tomography Can Contribute to Discriminate Patients with Poor Prognosis in Hormone Receptor-Positive Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
por: Moon, Yong Wha, et al.
Publicado: (2017)

Relationship of the standard uptake value of (18)F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm
por: Park, Soeun, et al.
Publicado: (2021)

Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging
por: Lee, Suk-Hyun, et al.
Publicado: (2021)

Diagnostic Accuracy and Confidence of [18F] FDG PET/MRI in comparison with PET or MRI alone in Head and Neck Cancer
por: Park, Jisang, et al.
Publicado: (2020)

Diagnostic value of (18)F-FDG PET/CT in discriminating between benign and malignant lesions of the ribs
por: Choi, Sunju, et al.
Publicado: (2022)

The Role of (18) F-FDG PET/CT in Assessing Therapy Response in Cervix Cancer after Concurrent Chemoradiation Therapy
por: Choi, Jiyoun, et al.
Publicado: (2013)

Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer
por: Kang, Seo Young, et al.
Publicado: (2017)

(18)F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value
por: Kim, Jin Suk, et al.
Publicado: (2014)

Prognostic Factors for Patients with Bone-Only Metastasis in Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Glucose Loading Enhances the Value of (18)F-FDG PET/CT for the Characterization and Delineation of Cerebral Gliomas
por: Kim, Dongwoo, et al.
Publicado: (2020)

Risk Factors for a False-Negative Result of Sentinel Node Biopsy in Patients with Clinically Node-Negative Breast Cancer
por: Lee, Seung Ah, et al.
Publicado: (2018)

CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer
por: Jung, Ji-hoon, et al.
Publicado: (2017)

Metabolic Super Scan in (18)F-FDG PET/CT Imaging
por: Kim, Dae-Weung, et al.
Publicado: (2010)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

Diagnostic and Predictive Values of (18)F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma
por: Hong, Il Ki, et al.
Publicado: (2020)

Prognostic value of the metabolic score obtained via [(18)F]FDG PET/CT and a new prognostic staging system for gastric cancer
por: Kim, Sung Hoon, et al.
Publicado: (2022)

Increased hepatic FDG uptake on PET/CT in hepatic sinusoidal obstructive syndrome
por: Kim, Honsoul, et al.
Publicado: (2016)

Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP
por: Ji, Jung Hwan, et al.
Publicado: (2022)

Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes
por: Kim, Gyuri, et al.
Publicado: (2015)

Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
por: Yoon, Ja Kyung, et al.
Publicado: (2022)

The Clinical Meaning of Benign Colon Uptake in (18)F-FDG PET: Comparison with Colonoscopic Findings
por: Roh, Sun Hee, et al.
Publicado: (2012)

Prognostic significance of preoperative (18)F-FDG PET/CT in uterine leiomyosarcoma
por: Park, Jeong-Yeol, et al.
Publicado: (2017)

FDG Uptake in PET by Bladder Hernia Simulating Inguinal Metastasis
por: Park, Sung Hee, et al.
Publicado: (2007)

Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2018)

(18)F‐FDG uptake in denervated muscles of patients with peripheral nerve injury
por: Choi, Ji Soo, et al.
Publicado: (2019)

Relationship Between (18)F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level
por: Lee, Jae-Hoon, et al.
Publicado: (2016)

Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy
por: Jung, Minkyu, et al.
Publicado: (2012)

Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection
por: Lee, Jeong Won, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vqpe9g6kfi3muis1gm0ic1vleq